Articles by Disease (Leukaemia)

Recent Innovations in Antibody-Mediated, Targeted Particulate Nanotechnology and Implications for Advanced Visualisation and Drug Delivery

Journal: Current Nanoscience
Volume: 6
Page: 560-570
Author(s): Francois Fay, Christopher J. Scott and Paul A. McCarron

Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors

Journal: Current Medicinal Chemistry
Volume: 17
Page: 4114-4133
Author(s): F. Anizon, A. A. Shtil, V. N. Danilenko and P. Moreau

Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway

Journal: Current Cancer Drug Targets
Volume: 10
Page: 824-833
Author(s): A. J. Weickhardt, N. C. Tebbutt and J. M. Mariadason

Gene Expression Profiling in Rodent Models for Schizophrenia

Journal: Current Neuropharmacology
Volume: 8
Page: 382-393
Author(s): Jessica E. Van Schijndel and Gerard J.M. Martens

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

Journal: Current Medicinal Chemistry
Volume: 17
Page: 4270-4290
Author(s): S. Salerno, F. Da Settimo, S. Taliani, F. Simorini, C. La Motta, G. Fornaciari and A. M. Marini

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

Journal: Current Medicinal Chemistry
Volume: 17
Page: 4326-4341
Author(s): P. Wu and Y.-Z. Hu

Intramolecular Cyclisation of β-Aryl-β-Amino Acids in the Design of Novel Heterocyclic Systems with Therapeutic Interest: An Unfailing Source of Diversity

Journal: Current Medicinal Chemistry
Volume: 17
Page: 4342-4369
Author(s): Christophe Rochais, Sylvain Rault and Patrick Dallemagne